This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed price of $6,065.75 and a completion date of March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of Ondansetron HCL 4 MG Tablet, a medication used to treat nausea and vomiting. The contract has a ceiling value of $24,183.47 and is a firm fixed-price, delivery order contract. The ultimate completion date is December 1, 2022. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 MG Tablets, a generic medication used to prevent nausea and vomiting. The delivery order has a ceiling value of $30,120.18 and is a firm fixed-price contract with a completion date of June 5, 2024. The contract does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,873.75 and a completion date of February 10, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 MG tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $16,741.02 and a completion date of April 4, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The delivery order has a ceiling value of $37,400.41 and is a firm fixed-price contract. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,584.18 and is a firm fixed-price delivery order with a completion date of June 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,178.92, is for the delivery of 4,562,459,098 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price delivery order, with no...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $8,894.00 and is a firm fixed-price delivery order, with an ultimate completion date of April 22, 2025. This contract is not designated as a set-aside and is open to full...